MedTrace Logo

Autologous Adipose Cells Therapy

NCT06869252 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-05-31

No results posted yet for this study

Summary

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Conditions

  • Hair Loss/Baldness
  • Wrinkle Appearance
  • Volume
  • Fine Lines
  • Skin Elasticity
  • Hair Thinning
  • Skin Pigmentation
  • Skin Texture

Interventions

BIOLOGICAL

Autologous Adipose Cells Therapy

Participants will receive Autologous Adipose Cells therapy treatment, and the safety and efficacy of the treatment will be monitored by the primary investigator up to 25 weeks.

Sponsors & Collaborators

  • CERM INC.

    lead INDUSTRY

Principal Investigators

  • Dr. Abdollah M. Malekzadeh, MD, MD · The Centre for Cosmetic Surgery & Medicine

  • Dr. Arun Kumar, PhD · CERM INC.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-11-01
Completion
2026-02-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06869252 on ClinicalTrials.gov